Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.43 |
| ▸ | PPM1B | O75688 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2952999 | 1.00 | SLC6A2 (0.46) | SLC6A2SLC6A4CYP2C19ALDH1A1LMNA | |
| SCHEMBL727158 | 1.00 | SLC6A2 (0.46) | SLC6A2SLC6A4CYP2C19ALDH1A1LMNA | |
| SCHEMBL16117460 | 1.00 | SLC6A2 (0.46) | SLC6A2SLC6A4CYP2C19ALDH1A1LMNA | |
| SCHEMBL15590800 | 1.00 | SLC6A2 (0.46) | SLC6A2SLC6A4CYP2C19ALDH1A1LMNA | |
| SCHEMBL2953605 | 1.00 | SLC6A2 (0.46) | SLC6A2SLC6A4CYP2C19ALDH1A1LMNA | |
| SCHEMBL16117467 | 1.00 | SLC6A2 (0.46) | SLC6A2SLC6A4CYP2C19ALDH1A1LMNA | |
| SCHEMBL30850208 | 1.00 | SLC6A2 (0.46) | SLC6A2SLC6A4CYP2C19ALDH1A1LMNA | |
| SCHEMBL3944070 | 1.00 | SLC6A2 (0.46) | SLC6A2SLC6A4CYP2C19ALDH1A1LMNA | |
| SCHEMBL12653679 | 0.98 | SLC6A2 (0.49) | SLC6A2SLC6A4CYP2C19ALDH1A1LMNA | |
| SCHEMBL13081194 | 0.98 | SLC6A2 (0.49) | SLC6A2SLC6A4CYP2C19ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 236 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4605346-A1 | MODIFIED LAYERED DOUBLE HYDROXIDE (LDH), PARTICLES COMPRISING SAID LDH, AND METHOD FOR PRODUCING SAID LDH | Kisuma Chemicals B.V. (NL) | 2025-08-27 | — | — | EP | claimed |
| CN-118724721-A | Fuel lubricity improver and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-10-01 | — | — | CN | claimed |
| WO-2024085755-A1 | MODIFIED LAYERED DOUBLE HYDROXIDE (LDH), PARTICLES COMPRISING SAID LDH, AND METHOD FOR PRODUCING SAID LDH | KISUMA CHEMICALS B.V. (NL) | 2024-04-25 | — | — | WO | claimed |
| CN-116143998-A | Bio-based hydroxyl-terminated hyperbranched polyester, preparation method thereof and application thereof as plasticizer | 上海交通大学 | 2023-05-23 | — | — | CN | claimed |
| CN-113292433-A | Synthesis method of trans-1, 2-cyclohexane dicarboxylic acid monomethyl ester | 上海凌凯医药科技有限公司 | 2021-08-24 | — | — | CN | claimed |
| EP-3397658-A1 | NON-PHTHALATE CATALYST SYSTEM AND ITS USE IN THE POLYMERIZATION OF OLEFINS | Braskem America, Inc. (US) | 2018-11-07 | — | — | EP | claimed |
| US-9771466-B2 | Glycol ether-based cyclohexanoate ester plasticizers and blends therefrom | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2017-09-26 | — | — | US | claimed |
| WO-2017117439-A1 | NON-PHTHALATE CATALYST SYSTEM AND ITS USE IN THE POLYMERIZATION OF OLEFINS | BRASKEM AMERICA, INC. (US) | 2017-07-06 | — | — | WO | claimed |
| US-6794482-B2 | Adhesion promoter additive comprising an unsaturated, amorphous polyester | DEGUSSA AG (DE) | 2004-09-21 | — | — | US | claimed |
| US-20040054075-A1 | Adhesion promoter additive comprising an unsaturated, amorphous polyester | DEGUSSA AG (DE) | 2004-03-18 | — | — | US | claimed |
| EP-0656341-B1 | Process for the production of cyclohexanedimethanol | EASTMAN CHEM CO (US) | 1998-04-22 | — | — | EP | claimed |
| EP-0656341-A1 | Process for the production of cydohexanedimethanol | EASTMAN CHEMICAL COMPANY (US) | 1995-06-07 | — | — | EP | claimed |
| US-5414159-A | Hydrogenation of dialkyl cyclohexanedicarboxylate to form cyclohexanedimethanol | EASTMAN CHEMICAL COMPANY (US) | 1995-05-09 | — | — | US | claimed |
| EP-4719605-A1 | CHEMICAL COMPOUNDS AND USES THEREOF | GlaxoSmithKline Intellectual Property (No.4) Limited (GB) | 2026-04-08 | — | — | EP | disclosed |
| US-20250281424-A1 | SMALL MOLECULE ANTAGONISTS OF PF4 | ZHOU YUHANG (US) | 2025-09-11 | — | — | US | disclosed |
| WO-2024246862-A1 | CHEMICAL COMPOUNDS AND USES THEREOF | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 4) LIMITED (GB) | 2024-12-05 | — | — | WO | disclosed |
| US-5114953-A | Peptides | UNIVERSITY OF FLORIDA (US) | 1992-05-19 | — | — | US | disclosed |
| US-5095137-A | Hypotensives | LABORATORI GUIDOTTI SPA (IT) | 1992-03-10 | — | — | US | disclosed |
| EP-0337348-A2 | Amides of cyclomethylen-1,2-bicarboxylic acids having therapeutical activity, processes for their preparation and pharmaceutical compositions containing them | Laboratori Guidotti S.p.A. (IT) | 1989-10-18 | — | — | EP | disclosed |
| US-4039529-A | Cycloaliphatic dicarbonyl containing azo dyestuffs | CIBA-GEIGY AG (CH) | 1977-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250281424-A1 | SMALL MOLECULE ANTAGONISTS OF PF4 | PF4, F12, F2 | SLC6A2 2137/4885SLC6A4 175/4885CYP2C19 2833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.